Veru, Inc. (VERU)
2.61
-0.03
(-1.14%)
USD |
NASDAQ |
Aug 24, 16:00
2.61
0.00 (0.00%)
After-Hours: 20:00
Veru Net Income (Quarterly) : -6.988M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.988M |
| March 31, 2026 | -3.093M |
| December 31, 2025 | -5.333M |
| September 30, 2025 | 1.304M |
| June 30, 2025 | -7.323M |
| March 31, 2025 | -7.852M |
| December 31, 2024 | -1.810M |
| September 30, 2024 | -8.549M |
| June 30, 2024 | -10.34M |
| March 31, 2024 | -8.703M |
| December 31, 2023 | -7.667M |
| September 30, 2023 | -10.86M |
| June 30, 2023 | -6.660M |
| March 31, 2023 | -33.79M |
| December 31, 2022 | -38.71M |
| September 30, 2022 | -41.02M |
| June 30, 2022 | -22.20M |
| March 31, 2022 | -14.18M |
| December 31, 2021 | -6.38M |
| September 30, 2021 | -4.294M |
| June 30, 2021 | -2.693M |
| March 31, 2021 | -2.846M |
| December 31, 2020 | 17.23M |
| September 30, 2020 | -11.83M |
| June 30, 2020 | -3.025M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.8105M |
| December 31, 2019 | -3.305M |
| September 30, 2019 | -3.060M |
| June 30, 2019 | -2.774M |
| March 31, 2019 | -4.034M |
| December 31, 2018 | -2.149M |
| September 30, 2018 | -7.920M |
| June 30, 2018 | -7.930M |
| March 31, 2018 | -3.831M |
| December 31, 2017 | -4.257M |
| September 30, 2017 | -2.679M |
| June 30, 2017 | -0.7899M |
| March 31, 2017 | -1.777M |
| December 31, 2016 | -1.366M |
| September 30, 2016 | -1.751M |
| June 30, 2016 | 0.5703M |
| March 31, 2016 | 0.035M |
| December 31, 2015 | 1.490M |
| September 30, 2015 | 0.7026M |
| June 30, 2015 | 1.171M |
| March 31, 2015 | 1.668M |
| December 31, 2014 | 0.8049M |
| September 30, 2014 | -0.5661M |
| June 30, 2014 | 1.160M |
| March 31, 2014 | 0.3751M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
| Lexicon Pharmaceuticals, Inc. | -31.78M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 6.988M |
| EPS Diluted (Quarterly) | -0.3032 |
| Enterprise Value | 21.90M |
| Earnings Yield | -23.41% |
| Normalized Earnings Yield | -28.50 |